HIGHFDA DEVICE

Philips Azurion Systems Recalled Due to Software Issues

Philips recalled 990 Azurion Systems on December 8, 2025, after nine software issues were identified. The defects may cause loss of X-ray functionality, system restarts, and other operational failures. Healthcare providers must stop using the devices immediately.

Official notice
PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.Health & Personal CareMedical DevicesSoftware Version: R3.0. 1. Model Number: 722229. UDI Numbers: (01)00884838116726(21)22(01)00884838116726(21)15(01)00884838116726(21)16

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DEVICE
Recall date
December 8, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
December 8, 2025
Hazard Level
HIGH
Brand
PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Medical Devices; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.
Product type
Medical Imaging Systems
Model numbers
Software Version: R3.0. 1. Model Number: 722229. UDI Numbers: (01)00884838116726(21)22, (01)00884838116726(21)15, (01)00884838116726(21)16, (01)00884838116726(21)6, (01)00884838116726(21)8, (01)00884838116726(21)4, (01)00884838116726(21)24, (01)00884838116726(21)26 +12 more
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    December 8, 2025

  2. Reported by FDA DEVICE

    January 21, 2026

  3. RecallRadar source check

    January 28, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Nine (9) identified software issues which may result in the following: loss of X-ray after Pedal Tap, loss of X-ray after Phase Fault, missing live X-ray on the FlexVision monitor, system continues to restart, AMD triple drive, C-Partition of Suite PC running out of free space, system remains in continuous restart mode after start-up, misalignment of Marker Tool Overlay, longitudinal position error.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. or your healthcare provider for instructions. Notification method: E-Mail

About This Product

Philips Azurion Systems are advanced medical imaging devices used in healthcare settings for diagnostic procedures. They provide real-time imaging capabilities crucial for effective patient care.

Why This Is Dangerous

The identified software issues can lead to critical failures in the imaging process, potentially jeopardizing patient safety during medical examinations.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

The recall requires immediate action from healthcare providers to avoid using malfunctioning equipment, which could disrupt patient care and diagnostic accuracy.

Practical Guidance

How to identify if yours is affected

  1. Locate the model number on your device
  2. Check if the model number matches the recalled list
  3. Review the recall notice for specific software version details

Where to find product info

The model number and software version can typically be found on the device's front panel or user manual.

What timeline to expect

Expect processing for refunds or replacements to take 4-6 weeks after contacting Philips.

If the manufacturer is unresponsive

  • Document all communication attempts with Philips
  • Reach out to your healthcare provider for assistance
  • File a report with the FDA if necessary

How to prevent similar issues

  • Regularly update software on medical devices
  • Stay informed about recalls in the medical device industry

Documentation advice

Keep records of all correspondence regarding the recall, including emails and receipts for any related purchases.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

The recall involves Philips Azurion Systems R3.0, including models 722229, 722230, 722231, 722232, 722235, 722236, 722233, and 722234. The systems were distributed worldwide, including the US and various countries. These models were sold globally.

Key Facts

  • Recalled models include Azurion 3 M12, M15, Azurion 5 M12, M20, and Azurion 7 models
  • Nine software issues identified
  • Stop using devices immediately
  • Contact Philips for instructions

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product Details

Model Numbers
Software Version: R3.0. 1. Model Number: 722229. UDI Numbers: (01)00884838116726(21)22
(01)00884838116726(21)15
(01)00884838116726(21)16
(01)00884838116726(21)6
(01)00884838116726(21)8
+15 more
Affected States
ALL
Report Date
January 21, 2026
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
HIGH

Philips Medical Systems Recalls Azurion 5 M12 Over Safety Risk

Philips Medical Systems recalled 326 Azurion 5 M12 systems on January 26, 2026. The table may move unexpectedly when the Reset Geometry button is pressed, posing a risk to patients and healthcare providers. Immediate cessation of use is advised.

PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.
Under certain
Read more